Compumedics Limited

Compumedics Limited is a world-leading designer and manufacturer of diagnostic and research technologies for sleep, neurodiagnostics, brain research, and ultrasonic blood flow monitoring. Founded in 1987 and listed on the Australian Securities Exchange (ASX: CMP) since 2000, the company has established itself as a primary supplier of polysomnography (PSG) systems, EEG amplifiers and recorders, and magnetoencephalography (MEG) equipment. The product portfolio includes comprehensive sleep diagnostics solutions spanning in-lab, home-based, ambulatory, and wireless configurations, as well as complete neurodiagnostic platforms supporting clinical EEG, long-term monitoring (LTM), ICU continuous EEG (cEEG), and high-channel-count research applications. The company offers proprietary software platforms—Profusion Sleep, Profusion EEG, Profusion neXus 360 for laboratory management, and CURRY for advanced brain analytics—alongside supporting accessories and consumables. Compumedics operates a global infrastructure with corporate headquarters in Abbotsford, Australia, and major regional hubs in Charlotte, North Carolina (USA), Dresden and Freiberg (Germany), Strasbourg (France), and Shenzhen (China). The company maintains over 15% investment in R&D and holds a Medical Advisory Board to ensure continued innovation. Products are distributed globally to clinical institutions, research centers, and pharmaceutical organizations conducting clinical trials. Regulatory credentials and specific certifications are not detailed in the accessible content, though the company's long operational history and ASX listing indicate substantial compliance infrastructure.